Fludeoxyglucose F 18 Injection, 20-300 mCi/mL at End of Synthesis (EOS) Solution, 50 mL glass vial, Rx only, Manufactured by Massachusetts General Hospital PET Center, Boston, MA NDC 76318-334-50
Published March 3, 2021 · Recall initiated: February 17, 2021
Summary
FDA records drug Class II recall D-0288-2021, published March 3, 2021 and initiated February 17, 2021. Recalling firm: The General Hospital Corporation; Status: Terminated; Reported quantity: 50 mL vial; Lot: Lot # P01-021721, exp 02/17/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility
What to do
Voluntary: Firm initiated · Telephone
Get an email if FLUDEOXYGLUCOSE F 18 has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- FLUDEOXYGLUCOSE F 18
- Manufacturer
- The General Hospital Corporation
- Distributor
- Product was distributed to one direct account.
- Lot
- Lot # P01-021721, exp 02/17/2021
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAImatinib Mesylate Tablets 100mg, packaged as a) 90-count bottles (NDC 43598-344-90); and b) For InstitutionalMarch 3, 2021
- FDAPublix Steam in Bag Season Butternut MedleyMarch 3, 2021
- FDACisatracurium Besylate Injection, USP, 10mg per 5mL (2 mg per mL), Single-Dose Vial (NDC 71288-712-05),March 3, 2021
- FDAPublix Steam in Bag Green Bean Butternut SquashMarch 3, 2021
- FDALeucovorin Calcium for Injection, USP, 350 mg/vial, Rx only, labeled as a) Teva Parenteral Medicines, Inc.,March 3, 2021
- FDAPublix Steam in Bag Butternut Brussels PecanMarch 3, 2021
Questions about this recall
Was Fludeoxyglucose F 18 Injection, 20-300 mCi/mL at End of Synthesis (EOS) Solution, 50 mL glass vial, Rx only, Manufactured by Massachusetts General Hospital PET Center, Boston, MA NDC 76318-334-50 recalled?
Yes. FDA published recall D-0288-2021 on March 3, 2021. Reported hazard: Lack of Assurance of Sterility
What should I do if I have this product?
Voluntary: Firm initiated · Telephone
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: FLUDEOXYGLUCOSE F 18.